Add BrightSurf on Google Email

The Lancet


A warning to gardeners

A gardener's death due to inhaling fungal spores from dead plant material has highlighted the risk of aspergillosis. The case report suggests that prompt treatment with an appropriate antifungal agent is vital in such cases.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 12, 2008

Carbocisteine can reduce worsening of COPD

A randomized controlled trial found carbocisteine significantly reduced yearly exacerbation rates in Chinese patients with COPD by 25% compared to placebo. This mucolytic drug may be a worthwhile treatment for prevention of exacerbations, particularly in developing countries.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 12, 2008

Oral prednisolone can be used to treat gout

A randomized clinical trial found that oral prednisolone is clinically equivalent to naproxen in reducing pain and inflammation in patients with gout. The study suggests that prednisolone could be a safer alternative for treating gout, with potential economic benefits due to reduced healthcare costs.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 29, 2008

The global challenge of diabetes

The current figure of 246 million adults worldwide with diabetes is expected to expand rapidly, with 50% of deaths attributed to cardiovascular disease. The Lancet Editorial emphasizes that much of the morbidity and mortality can be prevented through targeted prevention strategies.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 22, 2008

Early intensive insulin therapy in newly diagnosed type 2 diabetes patients improves glucose control

A randomized controlled trial found that early intensive insulin therapy improved blood glucose control and β-cell function in patients with newly diagnosed type 2 diabetes. The treatment, which included continuous subcutaneous insulin infusion or multiple daily insulin injections, resulted in higher remission rates and prolonged glyc...

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 22, 2008